RT @pmarsupia: Acaban de publicar los resultados de la Fase III del ensayo de la vacuna de Moderna. 👉🏽 De 14.500 personas vacunadas, 11 de…
RT @KizzyPhD: mRNA-1273 PEER-REVIEWED PHASE 3 DATA *anticlimax drumroll* if you read the FDA EUA package... “94.1% efficacy at preventing…
RT @virolvlog: ملخص لنتائج لقاح موديرنا التي نشرت بالأمس في NEJM 👇 https://t.co/7R0cb1G217 اللعب على المكشوف حلو .. مش كده! تم تضمين ≈30K…
RT @Mayanazatz: Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | NEJM. Vacina da Moderna mostra eficiência de 94% . A vantagem é…
@lovemoz1wtp @designsbycary @ladyred1956 @RojoRurba002 @navyvetbolt81 @JohnVetsResist1 @ozman7175 @JuliePi31415926 @ny_marine @AliVelshi @maddow Decades of technology and research. Looking forward to this day and the probability we would need to engineer t
RT @Nopanaden: Vacuna de ARNm de Moderna en @NEJM 👉🏻 30420 participantes. 👉🏻 185 infecciones en placebo Vs 11 en grupo vacunado. 👉🏻 30 caso…
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | NEJM https://t.co/aMkivW62WD
RT @Ekonsalud: Así se presenta una investigación seria sobre una vacuna para Covid-19. Esto es lo que quienes seguimos el criterio científi…
RT @OscarALizarazo: NIH-Moderna Vaccine https://t.co/ZuYYjvKPW7 patent applications disclosed in the "Disclosure of Potential Conflicts of…
Muy buenos resultados del estudio fase III de Moderna. Aunque no fue objetivo de estudio, la inmunogeneceidad luego de la 1era dosis es de >90%. Además aparentemente si previene por producir anticuerpos (más evaluación en curso) a contagiados asintomáti
If you wanna learn more about the Pfizer/Moderna vaccine, here’s the publication : https://t.co/e1jNSYjN5w (6/15)
Yeah baby
RT @GCHL19: About the Moderna vaccine: Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | NEJM https://t.co/BufBf2dJTx
Pech für die Ungeimpften! #Esken und Co werden sich ganz vorn einreihen. 🤮 https://t.co/AhkEtppG84
@Tijn28889141 De andere https://t.co/L5cdKIDw4N
About the Moderna vaccine: Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | NEJM https://t.co/BufBf2dJTx
RT @LindorffLarsen: Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine (Moderna) https://t.co/2Led86HCM0 https://t.co/eCfqWMzgGF
RT @skathire: Best paper of 2020. Published Dec 30, 2020. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | NEJM https://t.co/4Xx…
RT @BogochIsaac: Moderna's Phase 3 #COVID19 vaccine trial is now peer reviewed & online. These figures demonstrating vaccine efficacy, be…
RT @pmarsupia: Acaban de publicar los resultados de la Fase III del ensayo de la vacuna de Moderna. 👉🏽 De 14.500 personas vacunadas, 11 de…
RT @fjcarrascos: Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | NEJM https://t.co/3UwDwAYcYR
RT @pmarsupia: Acaban de publicar los resultados de la Fase III del ensayo de la vacuna de Moderna. 👉🏽 De 14.500 personas vacunadas, 11 de…
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine #Moderna https://t.co/0VlIrhzMAp
RT @pmarsupia: Acaban de publicar los resultados de la Fase III del ensayo de la vacuna de Moderna. 👉🏽 De 14.500 personas vacunadas, 11 de…
RT @DrFadloKhuri: Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | NEJM Congratulations to @AUB_Lebanon MD graduate Hana Al-Sahl…
RT @Ekonsalud: Así se presenta una investigación seria sobre una vacuna para Covid-19. Esto es lo que quienes seguimos el criterio científi…
RT @DeryaTR_: Moderna firmasının faz3 korona aşı sonuçları yayınlandı: 15 bin kişiye aşı 15 bin de plasebo (kontrol) yapıldı. 4 ay takip so…
Así se presenta una investigación seria sobre una vacuna para Covid-19. Esto es lo que quienes seguimos el criterio científico privilegiamos como información de seguridad. https://t.co/lMYfqqMaod
RT @hommel_b: https://t.co/xM8R8ArtbQ En daar is het tweede mRNA vaccin tegen het SARS-CoV-2 virus. Ditmaal van Moderna. #coronavaccin #…
RT @DeryaTR_: Moderna firmasının faz3 korona aşı sonuçları yayınlandı: 15 bin kişiye aşı 15 bin de plasebo (kontrol) yapıldı. 4 ay takip so…
RT @INTCFjusticia: Publicados en el @NEJM los resultados de la Fase III del ensayo de la vacuna de Moderna. https://t.co/nx2scZWcOz https:…
RT @hommel_b: https://t.co/xM8R8ArtbQ En daar is het tweede mRNA vaccin tegen het SARS-CoV-2 virus. Ditmaal van Moderna. #coronavaccin #…
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine https://t.co/7MmJmpV4cf
#covid19 #coronavirus #vaccine Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | NEJM https://t.co/Ya8eTDJUTq
RT @hommel_b: https://t.co/xM8R8ArtbQ En daar is het tweede mRNA vaccin tegen het SARS-CoV-2 virus. Ditmaal van Moderna. #coronavaccin #…
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | NEJM https://t.co/FALI0rsiqg
>severe obesity (body mass index [the weight in kilograms divided by the square of the height in meters] ≥40); しびあーだから(ふるえごえ
RT @skathire: Best paper of 2020. Published Dec 30, 2020. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | NEJM https://t.co/4Xx…
@qhusilu Claro que hay evidencia, otra cosa es que usted la desconozca.
RT @pmarsupia: Acaban de publicar los resultados de la Fase III del ensayo de la vacuna de Moderna. 👉🏽 De 14.500 personas vacunadas, 11 de…
RT @KizzyPhD: mRNA-1273 PEER-REVIEWED PHASE 3 DATA *anticlimax drumroll* if you read the FDA EUA package... “94.1% efficacy at preventing…
RT @gorka_orive: Resultados de la vacuna Moderna: Eficacia: 94,1% (185 COVID19 en placebo - 11 en vacuna). Eficacia similar entre grupos:…
RT @pmarsupia: Acaban de publicar los resultados de la Fase III del ensayo de la vacuna de Moderna. 👉🏽 De 14.500 personas vacunadas, 11 de…
RT @hommel_b: https://t.co/xM8R8ArtbQ En daar is het tweede mRNA vaccin tegen het SARS-CoV-2 virus. Ditmaal van Moderna. #coronavaccin #…
RT @robertoguerri: Looks good! Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | NEJM https://t.co/y8LrjVtBOu
RT @fjcarrascos: Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | NEJM https://t.co/3UwDwAYcYR
RT @ajcalac: Thankful to the 233 American Indians who participated in the #Moderna vaccine trial (https://t.co/ZEU7kTIiVN) – 94% efficacy i…
RT @ImMSanFer: Eficacia y seguridad de la vacina de Moderna en 30 mil sujetos (aleatorizados 1:1). Resultados fantásticos. Luz al final del…
RT @soysolisu: Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | NEJM https://t.co/cpNOqNaFSh
RT @F_Bethke: Just found that @moderna_tx published results for their #SARSCoV2 vaccine trial: https://t.co/A3stHEljlz However, like almos…
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | NEJM https://t.co/RNb65tBvR0
RT @laoneill111: Here’s the NEJM publication. Graph shows the remarkable efficacy- almost no infections in the vaccinated group (blue line)…
@CiudadanoCompr2 @La_SER Los resultados de Pfizer y Moderna están publicados en la New England Journal of Medicine. AMBOS. https://t.co/Zg5YnyZ3Sb https://t.co/r0ZAB4segy
RT @soysolisu: Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | NEJM https://t.co/cpNOqNaFSh
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | NEJM https://t.co/cpNOqNaFSh
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | NEJM https://t.co/EC3rGArc3O
@GTroikar @Alexand60933058 @ZeliszewskiD @nathanpsmad Un point confortant à évaluer concerne les résultats de la phase 3 du second vaccin à ARN (Moderna) récemment publiés: https://t.co/5F8AMGemCt
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | NEJM https://t.co/76enSB4eUe
RT @pmarsupia: Acaban de publicar los resultados de la Fase III del ensayo de la vacuna de Moderna. 👉🏽 De 14.500 personas vacunadas, 11 de…
RT @clairlemon: @Debb_Richards Here’s the Moderna data after peer review https://t.co/kcPVpOm3oS
RT @ArmandGirbes: Great. Two papers in NEJM on the RNA-based SARS-CoV-2 vaccine: https://t.co/kHq6lwkxuN and https://t.co/323tr2UgV0
RT @ArmandGirbes: Great. Two papers in NEJM on the RNA-based SARS-CoV-2 vaccine: https://t.co/kHq6lwkxuN and https://t.co/323tr2UgV0
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | NEJM https://t.co/TQQNbccj5B This article discusses the phase 3 randomized, observer-blinded, placebo-controlled trial of the mRNA-1273 vaccine conducted at 99 centers across the U.S.A. It enrolled
RT @sfarooqlrh: Clinical trial on efficacy of Moderna vaccine is published. Clinical science behind vaccine efficacy is worth reading. Effi…
https://t.co/BsWENo62UI Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
RT @pmarsupia: Acaban de publicar los resultados de la Fase III del ensayo de la vacuna de Moderna. 👉🏽 De 14.500 personas vacunadas, 11 de…
RT @YujiY0402: 引用文献: https://t.co/S7WX5K1dcB
RT @virolvlog: ملخص لنتائج لقاح موديرنا التي نشرت بالأمس في NEJM 👇 https://t.co/7R0cb1G217 اللعب على المكشوف حلو .. مش كده! تم تضمين ≈30K…
The Moderna vaccine trial results were published in the NEJM on 12/30 altho data were submitted to the FDA 2 weeks earlier. Study summary in graphics👇 Most injection-site (pain/swelling) & systemic effects (headache/fatigue/myalgia) resolved in 1-3 day
@MizzCreme @itzStephieLynne Just in case. https://t.co/sTcltPtM92
RT @skathire: Best paper of 2020. Published Dec 30, 2020. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | NEJM https://t.co/4Xx…
引用文献: https://t.co/S7WX5K1dcB
RT @Mayanazatz: Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | NEJM. Vacina da Moderna mostra eficiência de 94% . A vantagem é…
RT @DeryaTR_: Moderna firmasının faz3 korona aşı sonuçları yayınlandı: 15 bin kişiye aşı 15 bin de plasebo (kontrol) yapıldı. 4 ay takip so…
Phase 3 Trial Data for the #Moderna mRNA vaccine for #COVID-19 https://t.co/EMUafaNNUJ
Positive news: Moderna vaccine looking good. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | NEJM https://t.co/8T5DZOwAgR
Eficacia y seguridad de la vacina de Moderna en 30 mil sujetos (aleatorizados 1:1). Resultados fantásticos. Luz al final del túnel... y brilla- https://t.co/CScbWa9PQt
RT @ajcalac: Thankful to the 233 American Indians who participated in the #Moderna vaccine trial (https://t.co/ZEU7kTIiVN) – 94% efficacy i…
RT @ajcalac: Thankful to the 233 American Indians who participated in the #Moderna vaccine trial (https://t.co/ZEU7kTIiVN) – 94% efficacy i…
RT @Mayanazatz: Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | NEJM. Vacina da Moderna mostra eficiência de 94% . A vantagem é…
RT @DrMisialek: Efficacy and safety of the Moderna #COVID19 vaccine published https://t.co/lj8SKVDn0D @NEJM https://t.co/FL8pueCFxc
RT @DrMisialek: Efficacy and safety of the Moderna #COVID19 vaccine published https://t.co/lj8SKVDn0D @NEJM https://t.co/FL8pueCFxc
RT @ArmandGirbes: Great. Two papers in NEJM on the RNA-based SARS-CoV-2 vaccine: https://t.co/kHq6lwkxuN and https://t.co/323tr2UgV0
RT @ArmandGirbes: Great. Two papers in NEJM on the RNA-based SARS-CoV-2 vaccine: https://t.co/kHq6lwkxuN and https://t.co/323tr2UgV0
@DomiVerhagen @01benno Ik zoek verder met deze hulp:
RT @ArmandGirbes: Great. Two papers in NEJM on the RNA-based SARS-CoV-2 vaccine: https://t.co/kHq6lwkxuN and https://t.co/323tr2UgV0
RT @ArmandGirbes: Great. Two papers in NEJM on the RNA-based SARS-CoV-2 vaccine: https://t.co/kHq6lwkxuN and https://t.co/323tr2UgV0
Thankful to the 233 American Indians who participated in the #Moderna vaccine trial (https://t.co/ZEU7kTIiVN) – 94% efficacy in preventing symptomatic #COVID19. Glad to be on #TeamModerna, but might be starting a family rivalry since my father @dan4kids is
Great. Two papers in NEJM on the RNA-based SARS-CoV-2 vaccine: https://t.co/kHq6lwkxuN and https://t.co/323tr2UgV0
RT @Mayanazatz: Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | NEJM. Vacina da Moderna mostra eficiência de 94% . A vantagem é…
RT @oluma: Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | NEJM https://t.co/shsrkC3Gps
RT @EnferEvidente: A simple vista los datos son buenos... pero falta el análisis por grupos de edad, comorbilidades, sujetos que estaban in…
RT @BogochIsaac: Moderna's Phase 3 #COVID19 vaccine trial is now peer reviewed & online. These figures demonstrating vaccine efficacy, be…